Table 2.
ADA, cell proliferation and cytokine production after drug interruption
ADA+ patients | Months after interruption | ADA (OD) | Mitogenic index | IFN‐γ | IL‐13 | IL‐10 |
---|---|---|---|---|---|---|
1 | 14 | 2.111 | 4.64 | + | + | – |
2 | 12 | 2.752 | 19 | + | – | – |
3 | 16 | 2.438 | 8.07 | – | – | + |
4 | 17 | 0.806 | 0.35 | – | – | – |
5 | 69 | 1.313 | 13.6 | – | + | – |
6 | 99 | 2.160 | 0.68 | + | – | + |
7 | 88 | 2.110 | 19.9 | – | + | – |
8 | 96 | 0.281 | 11.97 | + | + | + |
ADA– patients | Months after interruption | ADA (OD) | Mitogenic index | IFN–γ | IL–13 | IL–10 |
---|---|---|---|---|---|---|
1 | 16 | 0.063 | 1.4 | – | – | – |
2 | 12 | 0.041 | 0.03 | + | + | – |
3 | 8 | 0.089 | 0.27 | – | – | – |
4 | 5 | 0.039 | 1.52 | – | – | – |
5 | 48 | 0.016 | 0.02 | – | – | – |
6 | 84 | 0.065 | 0.82 | – | – | – |
7 | 85 | 0.045 | 1.02 | – | – | – |
8 | 49 | 0.039 | 0.28 | – | – | – |
ADA = anti‐drug antibodies; OD = optical density; IFN = interferon; IL = interleukin.